Pharmacological priming of adipose-derived stem cells for paracrine VEGF production with deferoxamine

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 3, 2016, Pages E167-E176

  Liu, Guei Sheung ^a,b   Peshavariya, Hitesh M ^a,b   Higuchi, Masayoshi ^a   Chan, Elsa C ^a,b   Dusting, Gregory J ^a,b   Jiang, Fan ^a,c  

^a O'Brien Institute   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Adipose derived stem cells; Deferoxamine; Hypoxia inducible factor 1; Paracrine; Pharmacological preconditioning; Vascular endothelial growth factor

Indexed keywords

CELL ENGINEERING; CONTROLLED DRUG DELIVERY; CYTOLOGY; ENDOTHELIAL CELLS; STEM CELLS; TARGETED DRUG DELIVERY; TISSUE ENGINEERING;

ADIPOSE DERIVED STEM CELLS; DEFEROXAMINE; HYPOXIA-INDUCIBLE FACTOR 1; IN-VITRO; PARACRINE; PHARMACOLOGICAL PRECONDITIONING; REGENERATIVE MEDICINE; REGENERATIVE TISSUES; THERAPEUTIC ANGIOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

AMINES;

DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN; ANTIOXIDANT; BIOLOGICAL MARKER; COBALT; COBALT CHLORIDE; CONDITIONED MEDIUM; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN A;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; CELL EXPANSION; CELL MIGRATION; CELL REGENERATION; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; UPREGULATION; WOUND HEALING; ADIPOSE TISSUE; BIOSYNTHESIS; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHARMACOLOGY; STEM CELL;

ADIPOSE TISSUE; ANTIOXIDANTS; BIOMARKERS; COBALT; CULTURE MEDIA, CONDITIONED; DEFEROXAMINE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84961213155     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1796     Document Type: Article

References (48)

1. Baraniak PR, McDevitt TC. 2010; Stem cell paracrine actions and tissue regeneration. Regen Med 5: 121-143.
2. Beerepoot LV, Shima DT, Kuroki M et al. 1996; Up-regulation of vascular endothelial growth factor production by iron chelators. Cancer Res 56: 3747-3751.
3. Biswas S, Gupta MK, Chattopadhyay D et al. 2007; Insulin-induced activation of hypoxia-inducible factor-1 requires generation of reactive oxygen species by NADPH oxidase. Am J Physiol Heart Circ Physiol 292: H758-766.
4. Carnesecchi S, Carpentier JL, Foti M et al. 2006; Insulin-induced vascular endothelial growth factor expression is mediated by the NADPH oxidase NOX3. Exp Cell Res 312: 3413-3424.
5. Chu K, Jung KH, Kim SJ et al. 2008; Transplantation of human neural stem cells protect against ischemia in a preventive mode via hypoxia-inducible factor-1 alpha stabilization in the host brain. Brain Res 1207: 182-192.
6. Crisostomo PR, Wang M, Wairiuko GM et al. 2006; High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 26: 575-580.
7. Datla SR, Peshavariya H, Dusting GJ et al. 2007; Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro. Arterioscler Thromb Vasc Biol 27: 2319-2324.
8. Gimble JM, Katz AJ, Bunnell BA. 2007; Adipose-derived stem cells for regenerative medicine. Circ Res 100: 1249-1260.
9. Hastings CL, Kelly HM, Murphy MJ et al. 2012; Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. J Control Release 161: 73-80.
10. Hirsila M, Koivunen P, Xu L et al. 2005; Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J 19: 1308-1310.
11. Hong SJ, Traktuev DO, March KL. 2010; Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant 15: 86-91.
12. Howland MA. 1996; Risks of parenteral deferoxamine for acute iron poisoning. J Toxicol Clin Toxicol 34: 491-497.
13. Hsiao ST, Asgari A, Lokmic Z et al. 2012; Comparative Analysis of Paracrine Factor Expression in Human Adult Mesenchymal Stem Cells Derived from Bone Marrow, Adipose, and Dermal Tissue. Stem Cells Dev 21: 2189-2203.
14. 2-regulated prolyl hydroxylation. Science 292: 468-472.
15. Jeong YM, Sung YK, Kim WG et al. 2012; Ultraviolet B preconditioning enhances the hair growth-promoting effects of adipose-derived stem cells via generation of reactive oxygen species. Stem Cells Dev 22: 158-168.
16. Jiang F, Roberts SJ, Datla S et al. 2006; NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 48: 950-957.
17. Kanda Y, Hinata T, Kang SW et al. 2011; Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells. Life Sci 89: 250-258.
18. Kilroy GE, Foster SJ, Wu X et al. 2007; Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212: 702-709.
19. Kim JH, Song SY, Park SG et al. 2012; Primary involvement of NADPH oxidase 4 in hypoxia-induced generation of reactive oxygen species in adipose-derived stem cells. Stem Cells Dev 21: 2212-2221.
20. Kuhbier JW, Weyand B, Radtke C et al. 2010; Isolation, characterization, differentiation, and application of adipose-derived stem cells. Adv Biochem Eng Biotechnol 123: 55-105.
21. Laschke MW, Harder Y, Amon M et al. 2006; Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 12: 2093-2104.
22. Lee SH, Jin SY, Song JS et al. 2012; Paracrine effects of adipose-derived stem cells on keratinocytes and dermal fibroblasts. Ann Dermatol 24: 136-143.
23. Lin TM, Tsai JL, Lin SD et al. 2005; Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants. Stem Cells Dev 14: 92-102.
24. Liu GS, Peshavariya H, Higuchi M et al. 2012; Microphthalmia-associated transcription factor modulates expression of NADPH oxidase type 4: a negative regulator of melanogenesis. Free Radic Biol Med 52: 1835-1843.
25. Locke M, Windsor J, Dunbar PR. 2009; Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg 79: 235-244.
26. Maharaj AS, D'Amore PA. 2007; Roles for VEGF in the adult. Microvasc Res 74: 100-113.
27. Markel TA, Crisostomo PR, Wang M et al. 2007; Iron chelation acutely stimulates fetal human intestinal cell production of IL-6 and VEGF while decreasing HGF: the roles of p38, ERK, and JNK MAPK signaling. Am J Physiol Gastrointest Liver Physiol 292: G958-963.
28. Minchenko A, Bauer T, Salceda S et al. 1994; Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71: 374-379.
29. Murohara T, Shintani S, Kondo K. 2009; Autologous adipose-derived regenerative cells for therapeutic angiogenesis. Curr Pharm Des 15: 2784-2790.
30. Oh YT, Lee JY, Yoon H et al. 2008; Lipopolysaccharide induces hypoxia-inducible factor-1 alpha mRNA expression and activation via NADPH oxidase and Sp1-dependent pathway in BV2 murine microglial cells. Neurosci Lett 431: 155-160.
31. Pal R, Hanwate M, Jan M et al. 2009; Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med 3: 163-174.
32. Park BS, Kim WS, Choi JS et al. 2010; Hair growth stimulated by conditioned medium of adipose-derived stem cells is enhanced by hypoxia: evidence of increased growth factor secretion. Biomed Res 31: 27-34.
33. Pham I, Uchida T, Planes C et al. 2002; Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 283: L1133-L1142.
34. Potier E, Ferreira E, Dennler S et al. 2008; Desferrioxamine-driven upregulation of angiogenic factor expression by human bone marrow stromal cells. J Tissue Eng Regen Med 2: 272-278.
35. Sadat S, Gehmert S, Song YH et al. 2007; The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 363: 674-679.
36. Sanz-Ruiz R, Fernandez-Santos E, Dominguez-Munoa M et al. 2009; Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transplant 18: 245-254.
37. Schweitzer KS, Johnstone BH, Garrison J et al. 2011; Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 183: 215-225.
38. Shen X, Wan C, Ramaswamy G et al. 2009; Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice. J Orthop Res 27: 1298-1305.
39. Sinor AD, Irvin SM, Cobbs CS et al. 1998; Hypoxic induction of vascular endothelial growth factor (VEGF) protein in astroglial cultures. Brain Res 812: 289-291.
40. Song SY, Chung HM, Sung JH. 2010; The pivotal role of VEGF in adipose-derived-stem-cell-mediated regeneration. Expert Opin Biol Ther 10: 1529-1537.
41. Stubbs SL, Hsiao ST, Peshavariya HM et al. 2012; Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev 21: 1887-1896.
42. Sun HL, Liu YN, Huang YT et al. 2007; YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Oncogene 26: 3941-3951.
43. Takahashi M, Suzuki E, Oba S et al. 2010; Adipose tissue-derived stem cells inhibit neointimal formation in a paracrine fashion in rat femoral artery, Am J Physiol Heart Circ Physiol 298: H415-423.
44. Weng R, Li Q, Li H et al. 2010; Mimic hypoxia improves angiogenesis in ischaemic random flaps. J Plast Reconstr Aesthet Surg 63: 2152-2159.
45. Xia C, Meng Q, Liu LZ et al. 2007; Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67: 10823-10830.
46. Xin X, Yang S, Ingle G et al. 2001; Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 158: 1111-1120.
47. Yamakawa M, Liu LX, Date T et al. 2003; Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93: 664-673.
48. Zuk PA, Zhu M, Ashjian P et al. 2002; Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295.